SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2016 / Cilt: 22 - Sayı: 2

Evaluation of the Results of Conservative Management of Women with Tuboovarian Abscess; Single Tertiary Center Experience

Cenk YAŞA
Özlem DURAL
Ercan BAŞTU
Harika YUMRU
Ömer DEMİR
Funda Güngör UĞURLUCAN
Pages
90–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Due to high levels of success with antibiotherapy, immediate surgical managementshould always be performed in cases of rupture.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate results of patients with conservative management of tuboovarian abscess(TOA).STUDY DESIGN: A retrospective cohort study of women with TOA.
📊
Key Findings & Data:Between January 2012 andFebruary 2015, all women that hospitalized with diagnosis of TOA enrolled in this study.
💡
Conclusion & Impact:Due to high levels of success with antibiotherapy, immediate surgical managementshould always be performed in cases of rupture.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To evaluate results of patients with conservative management of tuboovarian abscess(TOA).STUDY DESIGN: A retrospective cohort study of women with TOA. Between January 2012 andFebruary 2015, all women that hospitalized with diagnosis of TOA enrolled in this study. Cases were analyzed with respect to age, parity, medical conditions, history of intra-uterine device use, size of TOA, Creactive protein (CRP) levels, white blood cell (WBC) count, CA-125 levels, antibiotic usage, hospitalization period.RESULTS: Thirty-nine patients with TOA included in to this study. Mean age was 38.2 ± 11.5 years.Mean size of TOA was 5. 7 ± 2.1 cm. In comparison between patients with abscesses <= 6cm or >6cm,TOA size is not associated with important outcomes including duration of antibiotherapy and duration ofhospitalization.CONCLUSION: Women with TOAs should be admitted to the hospital and immediately started in parenteral antibiotics. Due to high levels of success with antibiotherapy, immediate surgical managementshould always be performed in cases of rupture.

🔖

Cite This Article

YAŞA, C., DURAL, Ö., BAŞTU, E., YUMRU, H., DEMİR, Ö., UĞURLUCAN, F. G. (2016). Evaluation of the Results of Conservative Management of Women with Tuboovarian Abscess; Single Tertiary Center Experience. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 22 - Sayı: 2, 90–93. https://ajindex.com/articles/193463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Workowski KA, Berman S. Sexually transmitted disease treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-110.
  2. Jossens MO, Eskenazi B, Schachter J, Sweet RL. Risk factors for pelvic inflammatory disease. A case control study. Sex Transm Dis 1996;23:239-47.
  3. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993;36:433- 44. Landers DV, Sweet RL. Tubo-ovarian abscess: contempo- rary approach to management. Rev Infect Dis 1983;5:876- 84. Hiller N, Sella T, Lev-Sagi A, Fields S, Lieberman S. Computed tomographic features of tuboovarian abscess. J Reprod Med 2005;50:203-8.
  4. Gingsburg DS, Stern JL, Hamod KA, Genadry R, Spemnce MR. Tuboovarian abscess: a retrospective re- view. Am J Obstet Gynecol 1980;138:1055-8
  5. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta- lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991;164:1556-162.
  6. Kaplan AL, Jacobs WM, Ehresman JB. Aggressive man- agement of pelvic abscess. Am J Obstet Gynecol 1967; 98:482-7. Sweet RL Tubo-ovarian abscess. Pelvic Inflammatory Disease, pages 101-124, Taylor & Francis, London, UK, 2006. Dodson MG. Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation. J Reprod Med 1994; 39:285-96.
  7. Landers DV, Wolner-Hanssen P, Paavonen J, et al. Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. Am J Obstet Gynecol 1991;164:849-58.
  8. Walker CK, Landers DV, Ohm Smith MJ, et al. Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salp- ingitis. Sex Transm Dis 1991;18:119-23.
  9. Brunham RC, Binns B, Gujon F, et al. Etiology and out- come of acute pelvic inflammatory disease. J Infect Dis 1988;158:510-17.
  10. Sweet RL, Gall SA, Gibbs RS, et al. Multicenter clinical trials comparing cefotetan with moxolactam or cefoxitin as therapy for obstetrics and gynecologic infections. Am J Surg 1988;155:56-60.
  11. Joiner KA, Lowe BR, Dzink JL, Bartlett JG. Antibiotic levels in infected and sterile subcutaneous abscesses in mice. J Infect Dis 1981;143:487-94.
  12. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta- lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991;164:1556-61
  13. McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tubo